The Baishi clinical trial will help us learn more about the safety and immune response generated by an approved RSV vaccine (ABRYSVO®) in adults 60 years of age or older. By taking part in this clinical trial, you will receive the RSV vaccine while contributing to vaccine research that could help people around the world.